At a glance
Our objective is to make strategic investments in innovative companies with technologies and business models that change the way we develop drugs and treat patients.
We bring value to our portfolio companies through our knowledge in medicine, pharmaceutical development, regulatory/reimbursement aspects, management and expertise in bringing products to market. We drive our portfolio investments to successful exits.
- 2-3 new investments per year
- Active involvement to help portfolio companies develop
- Long term value creation
Our investment criteria
- Strong management team
- Ambitious vision
- Innovative technology
- Robust execution plan
- Over 100 million invested since 2008
- Cumulative equity raised by all companies: USD 500 million
- We led 12 out of the 15 last investment rounds
- Portfolio company achievements: 18 FDA clearances or CE marks, 2 IPOs